Intravenous cyclophosphamide and high dose corticosteroids improve MRI lesions in demyelinating syndrome in systemic lupus erythematosus.
Leung
Felix K
FK
Division of Rheumatology, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Fortin
Paul R
PR
D018501:Antirheumatic Agents / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D003711:Demyelinating Diseases / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007275:Injections, Intravenous; D020945:Lupus Vasculitis, Central Nervous System / Q000188:drug therapy* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage*
D018501:Antirheumatic Agents; D005938:Glucocorticoids; D003520:Cyclophosphamide; D011239:Prednisolone